Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Assets Average (2016 - 2025)

CorMedix (CRMD) has disclosed Assets Average for 12 consecutive years, with $788.5 million as the latest value for Q4 2025.

  • Quarterly Assets Average rose 702.82% to $788.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $788.5 million through Dec 2025, up 702.82% year-over-year, with the annual reading at $472.5 million for FY2025, N/A changed from the prior year.
  • Assets Average hit $788.5 million in Q4 2025 for CorMedix, up from $501.7 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $788.5 million in Q4 2025 to a low of $58.1 million in Q2 2023.
  • Historically, Assets Average has averaged $141.4 million across 5 years, with a median of $72.2 million in 2021.
  • Biggest five-year swings in Assets Average: fell 19.64% in 2022 and later surged 702.82% in 2025.
  • Year by year, Assets Average stood at $72.2 million in 2021, then dropped by 14.01% to $62.1 million in 2022, then increased by 19.62% to $74.2 million in 2023, then surged by 32.31% to $98.2 million in 2024, then soared by 702.82% to $788.5 million in 2025.
  • Business Quant data shows Assets Average for CRMD at $788.5 million in Q4 2025, $501.7 million in Q3 2025, and $201.1 million in Q2 2025.